Assessing potential glycemic overtreatment in persons at hypoglycemic risk

JAMA Internal Medicine

Volumn 174, Issue 2, 2014, Pages 259-268

  Tseng, Chin Lin ^a,b   Soroka, Orysya ^a   Maney, Miriam ^a   Aron, David C ^c,d   Pogach, Leonard M ^a,b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HEMOGLOBIN A1C; INSULIN; SULFONYLUREA;

AGED; AMBULATORY CARE; APHASIA; APRAXIA; ARTICLE; COGNITIVE DEFECT; COMORBIDITY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DEMENTIA; DIABETES MELLITUS; DYSPHASIA; END STAGE LIVER DISEASE; END STAGE RENAL DISEASE; EPILEPSY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART FAILURE; HEART INFARCTION; HEMIPLEGIA; HIGH RISK PATIENT; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; KIDNEY FUNCTION; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NEOPLASM; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; RETINOPATHY; STOMACH PARESIS; TRANSIENT ISCHEMIC ATTACK; VETERANS HEALTH;

AGED; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; MALE; MIDDLE AGED; RISK FACTORS; SULFONYLUREA COMPOUNDS; UNITED STATES; VETERANS;

EID: 84893566752     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.12963     Document Type: Article

References (52)

1. Pogach L, Aron D. Balancing hypoglycemia and glycemic control: a public health approach for insulin safety. JAMA. 2010;303(20):2076-2077.
2. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002-2012.
3. Moore TJ, Cohen MR, Furberg CD. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Arch Intern Med. 2007;167(16):1752-1759.
4. Adverse drug events: themagnitude of health risk is uncertain because of limited incidence data. GAO/HEHS-00-21. http://www.gao.gov/assets/230/228642. pdf. Accessed August 5, 2013.
5. Asuncion MM, Shaheen M, Ganesan K, et al. Increase in hypoglycemic admissions: California hospital discharge data. Ethn Dis. 2007;17(3):536-540.
6. Lipska K,Wang Y, Ross S, et al. National trends in hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries 1999-2010 [abstract 274-OR]. Paper presented at: 73rd Scientific Sessions American Diabetes Association; June 24, 2013; Chicago, IL.
7. Sarkar U, López A, Maselli JH, Gonzales R. Adverse drug events in U.S. adult ambulatory medical care. Health Serv Res. 2011;46(5):1517-1533.
8. Sarkar U, Karter AJ, Liu JY, Moffet HH, Adler NE, Schillinger D. Hypoglycemia is more common among type 2 diabetes patients with limited health literacy: the Diabetes Study of Northern California (DISTANCE). J Gen Intern Med. 2010;25(9): 962-968.
9. Green AJ, Fox KM, Grandy S; SHIELD Study Group. Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012;96(3):313-318.
10. Weitzman ER, Kelemen S, Quinn M, Eggleston EM, Mandl KD. Participatory surveillance of hypoglycemia and harms in an online social network. JAMA Intern Med. 2013;173(5):345-351.
11. Bonds DE,MillerME, Bergenstal RM, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909. doi:10.1136/bmj.b4909.
12. Zoungas S, Patel A, Chalmers J, et al; ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363(15):1410-1418.
13. Inzucchi SE, Bergenstal RM, Buse JB, et al; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-1379.
14. Brown AF, Mangione CM, Saliba D, Sarkisian CA; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J AmGeriatr Soc. 2003;51(5)(suppl):S265-S280.
15. Pogach LM, Brietzke SA, Cowan CL Jr., Conlin P, Walder DJ, Sawin CT; VA/DoD Diabetes Guideline Development Group. Development of evidence-based clinical practice guidelines for diabetes: the Department of Veterans Affairs/Department of Defense guidelines initiative. Diabetes Care. 2004;27(suppl 2):B82-B89.
16. Institute of Medicine. Committee on Identifying and Preventing Medication Errors: Preventing Medication Errors.Washington, DC: National Academies Press; 2006.
17. Agency for Healthcare Research and Quality. National Quality Measures Clearinghouse (NQMC). http://www.ahrq.gov/health-care-information/topics/topic- national-quality-measures-clearinghouse-nqmc.html. Accessed August 5, 2013.
18. DuckworthW, Abraira C, Moritz T, et al; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360(2):129-139.
19. Pogach L, Aron D. The other side of quality improvement in diabetes for seniors: a proposal for an overtreatment glycemic measure. Arch Intern Med. 2012;172(19):1510-1512.
20. Pogach LM, RajanM, ManeyM, Tseng CL, Aron DC. Hidden complexities in assessment of glycemic outcomes: are quality rankings aligned with treatment? Diabetes Care. 2010;33(10):2133-2139.
21. Garg R,Williams ME. Diabetes management in the kidney patient. Med Clin North Am. 2013;97(1):135-156.
22. MillerME, Bonds DE, Gerstein HC, et al ACCORD Investigators. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ. 2010;340:b5444. doi:10.1136/bmj.b5444.
23. Punthakee Z, MillerME, Launer LJ, et al; ACCORD Group of Investigators; ACCORD-MIND Investigators. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care. 2012;35(4):787-793.
24. National Committee for Quality Assurance. HEDIS 2011: Healthcare Effectiveness Data and Information Set.Washington, DC: National Committee for Quality Assurance. 2011. Technical Specifications; vol 2.
25. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH). The A1C test and diabetes. National Diabetes Information Clearinghouse (NDIC) website. http://diabetes.niddk.nih. gov/dm/pubs/a1ctest/. Accessed August 5, 2013.
26. State of Texas Office of Public Insurance Counsel; Department of State Health Services Center for Health Statistics. Guide to Texas HMO quality: 2012. http://www.opic.state.tx.us/images/publication/2012-Guide-to-Texas-HMO-Quality. pdf. Published February 2013. Accessed August 5, 2013.
27. Luft HS. Data and methods to facilitate delivery system reform: harnessing collective intelligence to learn from positive deviance. Health Serv Res. 2010;45(5, pt 2):1570-1580.
28. Bradley EH, Curry LA, Ramanadhan S, Rowe L, Nembhard IM, Krumholz HM. Research in action: using positive deviance to improve quality of health care. Implement Sci. 2009;4:25.
29. Kirkman MS, Briscoe VJ, Clark N, et al. Diabetes in older adults. Diabetes Care. 2012;35(12):2650-2664.
30. US Department of Veterans Affairs. VA-DoD guidelines for management of diabetes mellitus in primary care (2010). http://www.healthquality.va .gov/diabetes-mellitus.asp. Accessed August 5, 2013.
31. de Boer IH, Rue TC, Hall YN, Heagerty PJ,Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305(24):2532-2539.
32. Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the Aging, Demographics, and Memory Study. Neuroepidemiology. 2007;29(1-2):125-132.
33. American Geriatrics Society. Five things physicians and patients should question: Choosing Wisely: an initiative of the American Board of Internal Medicine. http://www.choosingwisely.org/doctor-patient-lists/american- geriatrics-society/. Accessed August 5, 2013.
34. Seaquist ER,MillerME, Bonds DE, et al; ACCORD Investigators. The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study. Diabetes Care. 2012;35(2):409-414. doi:10.2337/dc11-0996.
35. Lipska KJ,Warton EM, Huang ES, et al. HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care. 2013;36(11):3535-3542.
36. Bonds DE,MillerME, Dudl J, et al. Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: secondary analysis of the ACCORD clinical trial data. BMC Endocr Disord. 2012;12:5. doi:10.1186/1472-6823-12-5.
37. Bainbridge KE, Cowie CC, Rust KF, Fradkin JE. Mitigating case mix factors by choice of glycemic control performance measure threshold. Diabetes Care. 2008;31(9):1754-1760.
38. Kirsh S, HeinM, Pogach L, et al. Improving outpatient diabetes care. Am J Med Qual. 2012;27(3):233-240.
39. GelladW, Mor M, Zhao X, Donohue J, Good C. Variation in use of high-cost diabetes mellitus medications in the VA healthcare system. Arch Intern Med. 2012;172(20):1608-1609.
40. Gabbay RA, FriedbergMW, Miller-DayM, Cronholm PF, Adelman A, Schneider EC. A positive deviance approach to understanding key features to improving diabetes care in the medical home. Ann FamMed. 2013;11(suppl 1):S99-S107.
41. Chin MH, Drum ML, Jin L, Shook ME, Huang ES, Meltzer DO. Variation in treatment preferences and care goals among older patients with diabetes and their physicians. Med Care. 2008;46(3):275-286.
42. Hunt LM, Kreiner M, Brody H. The changing face of chronic illness management in primary care: a qualitative study of underlying influences and unintended outcomes. Ann FamMed. 2012;10(5):452-460.
43. Berkowitz SA, Aragon K, Hines J, Seligman H, Lee S, Sarkar U. Do clinical standards for diabetes care address excess risk for hypoglycemia in vulnerable patients? a systematic review. Health Serv Res. 2013;48(4):1299-1310.
44. US Department of Health and Human Services. Multiple chronic conditions: a strategic framework: optimum health and quality of life for individuals with multiple chronic conditions. http://www.hhs.gov/ash/initiatives/mcc/mcc- framework.pdf. Accessed August 5, 2013.
45. US Department of Health and Human Services. Federal response to adverse drug events. http://www.ofmq.com/Websites/ofmq/images/iipcncc/2012-calls/ade/ npp-federalresponsetoades-factsheet07252012v2.pdf. Accessed August 5, 2013.
46. Atkins D, Kupersmith J, Eisen S. The Veterans Affairs experience: comparative effectiveness research in a large health system. Health Aff (Millwood). 2010;29(10):1906-1912.
47. Pogach L, Aron DC. Sudden acceleration of diabetes quality measures. JAMA. 2011;305(7):709-710.
48. Let the sunshine in: new efforts to reveal the ties between doctors and drug firms. http://www .economist.com/news/business/21572784-new-efforts-reveal- ties-between-doctors-and-drug-firms-let-sunshine/. The Economist. Published March 2, 2013. Accessed August 5, 2013.
49. Policymaking, regulation, & strategy: meaningful use: what is meaningful use? Health IT.gov website. http://www.healthit.gov/policy- researchers-implementers/meaningful-use. Accessed August 5, 2013.
50. Cavanaugh K, Huizinga MM,Wallston KA, et al. Association of numeracy and diabetes control. Ann Intern Med. 2008;148(10):737-746.
51. Signorovitch JE, Macaulay D, Diener M, et al. Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs. Diabetes Obes Metab. 2013;15(4):335-341.
52. Hippocrates. Epidemics. Jones WHS, trans. Book I, §XI. http://www.eastridges.com/wesley/primum.html. Accessed August 5, 2013.